<code id='2CDBF3D68E'></code><style id='2CDBF3D68E'></style>
    • <acronym id='2CDBF3D68E'></acronym>
      <center id='2CDBF3D68E'><center id='2CDBF3D68E'><tfoot id='2CDBF3D68E'></tfoot></center><abbr id='2CDBF3D68E'><dir id='2CDBF3D68E'><tfoot id='2CDBF3D68E'></tfoot><noframes id='2CDBF3D68E'>

    • <optgroup id='2CDBF3D68E'><strike id='2CDBF3D68E'><sup id='2CDBF3D68E'></sup></strike><code id='2CDBF3D68E'></code></optgroup>
        1. <b id='2CDBF3D68E'><label id='2CDBF3D68E'><select id='2CDBF3D68E'><dt id='2CDBF3D68E'><span id='2CDBF3D68E'></span></dt></select></label></b><u id='2CDBF3D68E'></u>
          <i id='2CDBF3D68E'><strike id='2CDBF3D68E'><tt id='2CDBF3D68E'><pre id='2CDBF3D68E'></pre></tt></strike></i>

          explore

          explore

          author:hotspot    Page View:1816
          HHS 2020
          PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

          WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

          The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

          advertisement

          PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          ASCO: AstraZeneca says CAR
          ASCO: AstraZeneca says CAR

          AdobeCHICAGO—Anext-generationCAR-Ttherapywasabletosubstantiallyshrinktumorsinpatientswithlivercancer

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          What we need to know about Arena Bioworks

          AdobeI’vespentagooddealofmycareerthinkingabouthowwestructureandfundresearchinthebiomedicalsciencesin